ATPase Domain of Heat Shock protein 70—isoform 2—(Hsp70-2) and their role in activating the adaptive immune response: An in silico approach
A lot of molecules play fundamental roles in neoplasic processes and cancer. Heat shock proteins may enhance this severe pathology and favor the protumoral milieu. However, a look at the literature tells us that these molecules intervene in both to promote or attack cancer cells. In the case of breast cancer is known that Hsp70 (isoform 2) improve this establishment and progression in the patient, and is possible that the ATPase domain of Hsp70-2 favors this disease. Thus, is relevant to know if this molecular region has immunogenic activity as well as which epitopes are essential to stimulate immune cells, and whether could induce the attack of the tumor mass. In this aim, the immunogenicity of ATPase domain of Hsp70-2 was studied in silico. The results suggest that the majority of the molecule had immunogenic epitopes that boosts the immune response through activation of B cells and T cells. However, in vitro synthesis and in vivo experimental studies to evaluate the efficacy of this therapeutic candidate are required to ensure efficacy and safety in people.
Siegel R, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016; 66:7–30.
Howell A, Anderson A, Clark R, Duffy S, Evans D, Garcia-Closas M, et al. Risk determination and prevention of breast cancer. Breast Cancer Res. 2014; 16: 446.
Makki J. Diversity of Breast Carcinoma: Histological Subtypes and Clinical Relevance. Clin Med Insights Pathol. 2015;8:23–31
Suárez-Arroyo I, Feliz-Mosquea Y, Pérez-Laspiur J, Arju R, Giashuddin S, Maldonado-Martínez G, et al. The proteome signature of the inflammatory breast cancer plasma membrane identifies novel molecular markers of disease. Am J Cancer Res. 2016; 6(8): 1720–1740.
Ziegler YS, Moresco JJ, Tu PG, Yates JR 3rd and Nardulli AM. Plasma Membrane Proteomics of Human Breast Cancer Cell Lines Identifies Po¬tential Targets for Breast Cancer Diagnosis and Treatment. PLoS One 2014; 9: e102341.
Freeman BC, Yamamoto KR. 2002. Disassembly of transcriptional regulatory complexes by molecular chaperones. Science 296: 2232–2235.
Graham P, Henderson Brian, Extracellular cell stress (heat shock) proteins—immune responses and disease: an overview. Phil. Trans. R. Soc. B 373: 20160522.
Hightower LE. 1991. Heat shock, stress proteins, chaperones and proteotoxicity. Cell 66: 191–197.
Georgopolis C, Welch WJ. 1993. Role of the major heat shock proteins as molecular chaperones. Ann Rev Cell Biol 9: 601–634.
Murphy E. The HSP70 family and cancer. Carcinogenesis vol.34 no.6 pp.1181–1188, 2013.
Ciocca D, Calderwood S. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress & Chaperones (2005) 10 (2), 86–103.
Zorsi E, Bovini P. Inducible Hsp70 in the Regulation of Cancer Cell Survival: Analysis of Chaperone Induction, Expression and Activity. Cancers 2011, 3, 3921-3956
Sims J, McCready, Jay D. Extracellular Heat Shock Protein (Hsp)70 and Hsp90α Assist in Matrix Metalloproteinase-2 Activation and Breast Cancer Cell Migration and Invasion. PLoS One. 2011; 6(4): e18848.
Cheng Q, Chang JT, Geradts J, Neckers LM, Haystead T, Spector NL, et al. Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer. Breast Cancer Res. 2012;14:R62.
Straume O, Shimamura T, Lampa MJ, Carretero J, Øyan AM, Jia D, et al. Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer. Proc Natl Acad Sci U S A. 2012;109:8699–704.
Rohde M, Daugaard M, Jensen MH, Helin K, Nylandsted J, Jäättelä M. Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanisms. Genes Dev. 2005;19:570–82.
Bausero MA, Gastpar R, Multhoff G, Asea A. 2005 Alternative mechanism by which IFN-g enhances tumor recognition: active release of heat shock protein 72. J. Immunol. 175, 2900–2912.
Broquet AH, Thomas G, Masliah J, Trugnan G, Bachelet M. 2003 Expression of the molecular chaperone Hsp70 in detergent-resistant microdomains correlates with its membrane delivery and release. J. Biol. Chem. 278, 21 601–21 606.
Multhoff G, Botzler C, Wiesnet M, Muller E, Meier T, Wilmanns W 1995 A stress-inducible 72-kDa heatshock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cells. Int. J. Cancer 61, 272–279.
Pfister K et al. 2007 Patient survival by Hsp70 membrane phenotype: association with different routes of metastasis. Cancer 110, 926–935.
Gehrmann M et al. 2012 Immunotherapeutic targeting of membrane hsp70-expressing tumors using recombinant human granzyme B. PLoSONE 7, e41341.
Gehrmann J, Marienhagen J, Eichholtz-Wirth H, Fritz E, Ellwart J. Dual function of membrane-bound heat shock protein 70 (Hsp70), Bag-4, and Hsp40: protection against radiation-induced effects and target structure for natural killer cells. Cell Death and Differentiation (2005) 12, 38–51.
Jagadish N, Agarwal S, Gupta N, Fatima R, Devi S, Kumar V, et al. Heat shock protein 70-2 (HSP70-2) overexpression in breast cancer. Jagadish et al. Journal of Experimental & Clinical Cancer Research (2016) 35:150.
Grote A, Hiller K, Scheer M, Munch R, Nortemann B, Hempel DC, et al. JCat: a novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W526-31.
Doytchinova I, Flower D. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics. 2007 8:4.
Rost B, Yachdav G, Liu J. The PredictProtein server. Nucleic Acid Res. 32: 321-326 (2004).
Zhang Y. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics, 9: 40 (2008).
Viklund H, Elofsson A. Improving topology prediction by two-track ANN-based preference scores and an extended topological. Bioinformatics. 2008.
Mathews D, Disney M, Childs J, Schroeder S, Zuker M, Turner D. Incorporating chemical modification constraints into a dynamic programming algorithm for prediction of RNA secondary structure. Proc Natl Acad Sci U S A. 2004 May 11; 101(19): 7287–7292.
Evdonin AL, Martynova MG, Bystrova OA, Guzhova IV, Margulis BA, Medvedeva ND. 2006 The release of Hsp70 from A431 carcinoma cells is mediated by secretory-like granules. Eur. J. Cell Biol. 85, 443–455.
Evdonin AL, Guzhova IV, Margulis BA, Medvedeva ND. 2004 Phospholipase C inhibitor, U73122, stimulates release of hsp-70 stress protein from A431 human carcinoma cells. Cancer Cell Int. 4, 2.
Thery C, Zitvogel L, Amigorena S. 2002 Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2, 569–579.
Chaput N, Taıeb J, Schartz NE, Andre F, Angevin E, Zitvogel L. 2004 Exosome-based immunotherapy. Cancer Immunol. Immunother. 53, 234–239.
Cordonnier M, Chanteloup G, Isambert N, Seigneuric R, Fumoleau P, Garrido C, Gobbo J. 2017 Exosomes in cancer theranostic: diamonds in the rough. Cell Adhes. Migr. 11, 151–163.
van Eden W, van der Zee R, Prakken B. 2005 Heat shock proteins induce T-cell regulation of chronic inflammation. Nat. Immunol. 5, 318–330.
Tanaka S et al. 1999 Activation of T cells recognizing an epitope of heat-shock protein 70 can protect against rat adjuvant arthritis. J. Immunol. 163, 5560–5565.
Owen J, Punt J, Stranford J. Kuby: Immunology. 7th ed. New York: W. H. Freeman and Company 2013; pp. 835-31.
Shevach E. Regulatory/suppressor T cells. In William P eds .Fundamental Immunology. 6th ed. Philadelphia, USA: Lippincott Williams & Wilkins 2008; pp. 1646-1315.